ARCHIVES

Cancer Policy: Reports Lists 10 Recommendations TO Improve Quality of Care, Measurement

This article is from The Cancer Letter archive.

Vol. 25 No. 14 | April 9, 1999

Download PDF Visit The Full Archive

Related Articles

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

NCI Cooperative Group Clinical Trials Listed

April 24, 2009

Conferees Set NIH Funding At $30 Billion.

November 2, 2007

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

Medenica’s Claims Of Association On CV, Brochures, Challenged By Some Institutions

April 30, 1993

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006